Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates

Journal of Thrombosis and Haemostasis

Volumn 11, Issue 7, 2013, Pages 1341-1352

  Puy, C ^a,b   Tucker, E I ^a,c   Wong, Z C ^a   Gailani, D ^d   Smith, S A ^e   Choi, S H ^e   Morrissey, J H ^e   Gruber, A ^a,b,c   Mccarty, O J T ^a,b,f  

^a Oregon Health and Science University Department of Biomedical Engineering   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Aronora Inc   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Factor XI; Factor XII; Polyphosphate; Thrombin generation; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 12A; ENOXAPARIN; KALLIKREIN; POLYPHOSPHATE; PREKALLIKREIN; PROCOAGULANT; PROTHROMBIN; RIVAROXABAN; THROMBIN;

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; EX VIVO STUDY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; PRIORITY JOURNAL; THROMBIN TIME;

FACTOR XI; FACTOR XII; POLYPHOSPHATE; THROMBIN GENERATION; THROMBOSIS;

ANIMALS; ANTIBODIES, NEUTRALIZING; BLOOD COAGULATION; FACTOR XI; FACTOR XI DEFICIENCY; FACTOR XIA; FACTOR XII; FACTOR XIIA; HUMANS; PLANT PROTEINS; POLYPHOSPHATES; PROTHROMBIN; THROMBIN; THROMBOSIS; TIME FACTORS;

EID: 84880429999     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12295     Document Type: Article

References (53)

1. Kornberg A, Rao NN, Ault-Riché D. Inorganic polyphosphate: a molecule of many functions. Annu Rev Biochem 1999; 68: 89-125.
2. Ruiz FA, Lea CR, Oldfield E, Docampo R. Human platelet dense granules contain polyphosphate and are similar to acidocalcisomes of bacteria and unicellular eukaryotes. J Biol Chem 2004; 279: 44250-7.
3. Müller F, Mutch NJ, Schenk WA, Smith SA, Esterl L, Spronk HM, Schmidbauer S, Gahl WA, Morrissey JH, Renné T. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 2009; 139: 1143-56.
4. Mackman N, Gruber A. Platelet polyphosphate: an endogenous activator of coagulation factor XII. J Thromb Haemost 2010; 8: 865-7.
5. Smith SA, Choi SH, Davis-Harrison R, Huyck J, Boettcher J, Rienstra CM, Morrissey JH. Polyphosphate exerts differential effects on blood clotting, depending on polymer size. Blood 2010; 116: 4353-9.
6. Smith SA, Mutch NJ, Baskar D, Rohloff P, Docampo R, Morrissey JH. Polyphosphate modulates blood coagulation and fibrinolysis. Proc Natl Acad Sci USA 2006; 103: 903-8.
7. Choi SH, Smith SA, Morrissey JH. Polyphosphate is a cofactor for the activation of factor XI by thrombin. Blood 2011; 118: 6963-70.
8. Colman RW, Schmaier AH. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 1997; 90: 3819-43.
9. Ratnoff OD, Colopy JE. A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. J Clin Invest 1955; 34: 602-13.
10. Seligsohn U. Factor XI deficiency in humans. J Thromb Haemost 2009; 7(Suppl. 1): 84-7.
11. Mackman N, Tilley RE, Key NS. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol 2007; 27: 1687-93.
12. Kravtsov DV, Matafonov A, Tucker EI, Sun M-F, Walsh PN, Gruber A, Gailani D. Factor XI contributes to thrombin generation in the absence of factor XII. Blood 2009; 114: 452-8.
13. Meijers JC, Tekelenburg WL, Bouma BN, Bertina RM, Rosendaal FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 2000; 342: 696-701.
14. Salomon O, Steinberg DM, Koren-Morag N, Tanne D, Seligsohn U. Reduced incidence of ischemic stroke in patients with severe factor XI deficiency. Blood 2008; 111: 4113-7.
15. Cheng Q, Tucker EI, Pine MS, Sisler I, Matafonov A, Sun M-F, White-Adams TC, Smith SA, Hanson SR, McCarty OJT, Renné T, Gruber A, Gailani D. A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo. Blood 2010; 116: 3981-9.
16. Tucker EI, Marzec UM, White TC, Hurst S, Rugonyi S, McCarty OJT, Gailani D, Gruber A, Hanson SR. Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI. Blood 2009; 113: 936-44.
17. Renné T, Pozgajová M, Grüner S, Schuh K, Pauer H-U, Burfeind P, Gailani D, Nieswandt B. Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 2005; 202: 271-81.
18. Wang X, Cheng Q, Xu L, Feuerstein GZ, Hsu M-Y, Smith PL, Seiffert DA, Schumacher WA, Ogletree ML, Gailani D. Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice. J Thromb Haemost 2005; 3: 695-702.
19. Itakura A, Aslan JE, Sinha S, White-Adams TC, Patel IA, Meza-Romero R, Vandenbark AA, Burrows GG, Offner H, McCarty OJ. Characterization of human platelet binding of recombinant T cell receptor ligand. J Neuroinflammation 2010; 7: 75.
20. Berny MA, Patel IA, White-Adams TC, Simonson P, Gruber A, Rugonyi S, McCarty OJT. Rational design of an ex vivo model of thrombosis. Cell Mol Bioeng 2010; 3: 187-9.
21. White-Adams TC, Berny MA, Patel IA, Tucker EI, Gailani D, Gruber A, McCarty OJT. Laminin promotes coagulation and thrombus formation in a factor XII-dependent manner. J Thromb Haemost 2010; 8: 1295-301.
22. Seligsohn U, Osterud B, Brown SF, Griffin JH, Rapaport SI. Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII. J Clin Invest 1979; 64: 1056-65.
23. Stief TW. Kallikrein activates prothrombin. Clin Appl Thromb Hemost 2008; 14: 97-8.
24. Matafonov A, Sarilla S, Sun M, Sheehan JP, Serebrov V, Verhamme IM, Gailani D. Activation of factor XI by products of prothrombin activation. Blood 2011; 118: 437-45.
25. Kleinschnitz C, Stoll G, Bendszus M, Schuh K, Pauer H-U, Burfeind P, Renné C, Gailani D, Nieswandt B, Renné T. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. J Exp Med 2006; 203: 513-8.
26. Tucker EI, Verbout NG, Leung PY, Hurst S, McCarty OJT, Gailani D, Gruber A. Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsis. Blood 2012; 119: 4762-8.
27. Leung PY, Hurst S, Berny-Lang MA, Verbout NG, Gailani D, Tucker EI, Wang RK, McCarty OJT, Gruber A. Inhibition of Factor XII-Mediated Activation of Factor XI Provides Protection Against Experimental Acute Ischemic Stroke in Mice. Transl Stroke Res 2012; 3: 381-9.
28. Kannemeier C, Shibamiya A, Nakazawa F, Trusheim H, Ruppert C, Markart P, Song Y, Tzima E, Kennerknecht E, Niepmann M, von Bruehl M-L, Sedding D, Massberg S, Günther A, Engelmann B, Preissner KT. Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc Natl Acad Sci USA 2007; 104: 6388-93.
29. Wilner GD, Nossel HL, LeRoy EC. Activation of Hageman factor by collagen. J Clin Invest 1968; 47: 2608-15.
30. van der Meijden PEJ, Munnix ICA, Auger JM, Govers-Riemslag JWP, Cosemans JMEM, Kuijpers MJE, Spronk HM, Watson SP, Renné T, Heemskerk JWM. Dual role of collagen in factor XII-dependent thrombus formation. Blood 2009; 114: 881-90.
31. von Brühl ML, Stark K, Steinhart A, Chandraratne S, Konrad I, Lorenz M, Khandoga A, Tirniceriu A, Coletti R, Köllnberger M, Byrne RA, Laitinen I, Walch A, Brill A, Pfeiler S, Manukyan D, Braun S, Lange P, Riegger J, Ware J, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012; 209: 819-35.
32. Konings J, Govers-Riemslag JWP, Philippou H, Mutch NJ, Borissoff JI, Allan P, Mohan S, Tans G, ten Cate H, Ariëns RAS. Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin. Blood 2011; 118: 3942-51.
33. Rao NN, Roberts MF, Torriani A. Amount and chain length of polyphosphates in Escherichia coli depend on cell growth conditions. J Bacteriol 1985; 162: 242-7.
34. Johne J, Blume C, Benz PM, Pozgajová M, Ullrich M, Schuh K, Nieswandt B, Walter U, Renné T. Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma. Biol Chem 2006; 387: 173-8.
35. Oschatz C, Maas C, Lecher B, Jansen T, Björkqvist J, Tradler T, Sedlmeier R, Burfeind P, Cichon S, Hammerschmidt S, Müller-Esterl W, Wuillemin WA, Nilsson G, Renné T. Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo. Immunity 2011; 34: 258-68.
36. Maas C, Govers-Riemslag JWP, Bouma B, Schiks B, Hazenberg BPC, Lokhorst HM, Hammarström P, ten Cate H, De Groot PG, Bouma BN, Gebbink MFBG. Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation. J Clin Invest 2008; 118: 3208-18.
37. Revak SD, Cochrane CG, Bouma BN, Griffin JH. Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma. J Exp Med 1978; 147: 719-29.
38. Osterud B, Bouma BN, Griffin JH. Human blood coagulation factor IX. Purification, properties, and mechanism of activation by activated factor XI. J Biol Chem 1978; 253: 5946-51.
39. Qian Y, Pan J, Zhou X, Weiser P, Lu H, Zhang L. Molecular mechanism underlines heparin-induced thrombocytopenia and thrombosis. Prog Mol Biol Transi Sci 2010; 93: 395-421.
40. Colman RW. The role of plasma proteases in septic shock. N Engl J Med 1989; 320: 1207-9.
41. Herwald H, Mörgelin M, Olsén A, Rhen M, Dahlbäck B, Müller-Esterl W, Björck L. Activation of the contact-phase system on bacterial surfaces-a clue to serious complications in infectious diseases. Nat Med 1998; 4: 298-302.
42. Noegel A, Gotschlich EC. Isolation of a high molecular weight polyphosphate from Neisseria gonorrhoeae. J Exp Med 1983; 157: 2049-60.
43. Tinsley CR, Manjula BN, Gotschlich EC. Purification and characterization of polyphosphate kinase from Neisseria meningitidis. Infect Immun 1993; 61: 3703-10.
44. Kumble KD, Kornberg A. Inorganic polyphosphate in mammalian cells and tissues. J Biol Chem 1995; 270: 5818-22.
45. Doggen CJM, Rosendaal FR, Meijers JCM. Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII. Blood 2006; 108: 4045-51.
46. Salomon O, Steinberg DM, Zucker M, Varon D, Zivelin A, Seligsohn U. Patients with severe factor XI deficiency have a reduced incidence of deep vein thrombosis. Thromb Haemost 2011; 105: 269-73.
47. Halbmayer WM, Mannhalter C, Feichtinger C, Rubi K, Fischer M. Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction. Wien Med Wochenschr 1993; 143: 43-50.
48. Kuhli C, Scharrer I, Koch F, Ohrloff C, Hattenbach L-O. Factor XII deficiency: a thrombophilic risk factor for retinal vein occlusion. Am J Ophthalmol 2004; 137: 459-64.
49. Girolami A, Randi ML, Gavasso S, Lombardi AM, Spiezia F. The occasional venous thromboses seen in patients with severe (homozygous) FXII deficiency are probably due to associated risk factors: a study of prevalence in 21 patients and review of the literature. J Thromb Thrombolysis 2004; 17: 139-43.
50. Endler G, Marsik C, Jilma B, Schickbauer T, Quehenberger P, Mannhalter C. Evidence of a U-shaped association between factor XII activity and overall survival. J Thromb Haemost 2007; 5: 1143-8.
51. Zito F, Drummond F, Bujac SR, Esnouf MP, Morrissey JH, Humphries SE, Miller GJ. Epidemiological and genetic associations of activated factor XII concentration with factor VII activity, fibrinopeptide A concentration, and risk of coronary heart disease in men. Circulation 2000; 102: 2058-62.
52. Colhoun HM, Zito F, Norman Chan N, Rubens MB, Fuller JH, Humphries SE. Activated factor XII levels and factor XII 46C>T genotype in relation to coronary artery calcification in patients with type 1 diabetes and healthy subjects. Atherosclerosis 2002; 163: 363-9.
53. Grundt H, Nilsen DWT, Hetland Ø, Valente E, Fagertun HE. Activated factor 12 (FXIIa) predicts recurrent coronary events after an acute myocardial infarction. Am Heart J 2004; 147: 260-6.